Sinopharm Group (01099) Announces January 2026 Monthly Return with No Change in Share Movements

Bulletin Express02-05 06:44

Sinopharm Group Co. Ltd. (Stock Code: 01099) submitted a Monthly Return for the period ended 31 January 2026, confirming no changes to its share capital. The total authorized/registered share capital of RMB 3,120,656,191 remains divided into 1,341,810,740 H shares and 1,778,845,451 domestic shares, each with a par value of RMB 1. The document also notes that, as the company is incorporated in the People’s Republic of China, the concept of authorized share capital is not directly applicable.

All issued H shares stood at 1,341,810,740 shares with no shares held in treasury. For domestic shares, the figure remained 1,778,845,451. The firm confirmed compliance with the applicable public float requirement, specified at an initial 25 percent threshold for this category. The submission, dated 5 February 2026, stated that there were no share option arrangements, warrants, or convertible securities in issue during the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1157938285?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 06:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157938285","market":"us","top_or_hot":-1,"title":"Sinopharm Group (01099) Announces January 2026 Monthly Return with No Change in Share Movements","media":"Bulletin Express","content":"<p>Sinopharm Group Co. Ltd. (Stock Code: 01099) submitted a Monthly Return for the period ended 31 January 2026, confirming no changes to its share capital. The total authorized/registered share capital of RMB 3,120,656,191 remains divided into 1,341,810,740 H shares and 1,778,845,451 domestic shares, each with a par value of RMB 1. The document also notes that, as the company is incorporated in the People’s Republic of China, the concept of authorized share capital is not directly applicable.</p>\n<p>All issued H shares stood at 1,341,810,740 shares with no shares held in treasury. For domestic shares, the figure remained 1,778,845,451. The firm confirmed compliance with the applicable public float requirement, specified at an initial 25 percent threshold for this category. The submission, dated 5 February 2026, stated that there were no share option arrangements, warrants, or convertible securities in issue during the period.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinopharm Group (01099) Announces January 2026 Monthly Return with No Change in Share Movements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinopharm Group (01099) Announces January 2026 Monthly Return with No Change in Share Movements\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-05 06:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinopharm Group Co. Ltd. (Stock Code: 01099) submitted a Monthly Return for the period ended 31 January 2026, confirming no changes to its share capital. The total authorized/registered share capital of RMB 3,120,656,191 remains divided into 1,341,810,740 H shares and 1,778,845,451 domestic shares, each with a par value of RMB 1. The document also notes that, as the company is incorporated in the People’s Republic of China, the concept of authorized share capital is not directly applicable.</p>\n<p>All issued H shares stood at 1,341,810,740 shares with no shares held in treasury. For domestic shares, the figure remained 1,778,845,451. The firm confirmed compliance with the applicable public float requirement, specified at an initial 25 percent threshold for this category. The submission, dated 5 February 2026, stated that there were no share option arrangements, warrants, or convertible securities in issue during the period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01099","symbol_name":"国药控股","start_time":0,"source_url":"","article_id":"1157938285","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157938285","pubTimestamp":1770245075,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinopharm Group Co. Ltd. (Stock Code: 01099) submitted a Monthly Return for the period ended 31 January 2026, confirming no changes to its share capital. The total authorized/registered share capital...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01099":"国药控股"},"translate_title":"国药集团(01099)公布2026年1月股份变动月报表无变动","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"Sinopharm Group Co. Ltd. (Stock Code: 01099) submitted a Monthly Return for the period ended 31 January 2026, confirming no changes to its share capital. The total authorized/registered share capital of RMB 3,120,656,191 remains divided into 1,341,810,740 H shares and 1,778,845,451 domestic shares, each with a par value of RMB 1. The document also notes that, as the company is incorporated in the People’s Republic of China, the concept of authorized share capital is not directly applicable.\nAll issued H shares stood at 1,341,810,740 shares with no shares held in treasury. For domestic shares, the figure remained 1,778,845,451. The firm confirmed compliance with the applicable public float requirement, specified at an initial 25 percent threshold for this category. The submission, dated 5 February 2026, stated that there were no share option arrangements, warrants, or convertible securities in issue during the period.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1157938285","isCrawlerRequest":true}